In community-acquired bacterial pneumonia, lefamulin was noninferior to moxifloxacin at 96 h after the first dose
- 18 February 2020
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 172 (4), JC22
- https://doi.org/10.7326/acpj202002180-022
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Pleuromutilins: Potent Drugs for Resistant Bugs—Mode of Action and ResistanceCold Spring Harbor Perspectives in Medicine, 2016